-
Mashup Score: 1How do we unlock the potential of digital health? - 9 day(s) ago
Unlock the power of digital health through AI and clinical advancements. Learn how these technologies are shaping the future of healthcare and how to harness their potential.
Source: pharmaphorum.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0What pharma stands to gain from technological innovation - 9 day(s) ago
Pharmaceutical companies stand to gain significant benefits from technological innovation in the form of improved data analytics, streamlined healthcare processes, and enhanced patient outcomes. Explore the potential advantages for the pharma industry.
Source: pharmaphorum.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 14Smart sensor cleared for use with AZ asthma, COPD inhalers - 18 day(s) ago
A smart sensor developed by Adherium has been cleared by the FDA for use with AstraZeneca’s asthma inhaler Airsupra and Breztri for COPD.
Source: pharmaphorum.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0Praia emerges with $20m for digital health platform - 29 day(s) ago
Healthcare system Providence has spun out a new company, Praia Health, focused on a platform to build and sustain connections between patients and health providers.
Source: pharmaphorum.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0ALS body takes digital approach to clinical trials access - 2 month(s) ago
The ALS Association is partnering with myTomorrows to connect patients and physicians with clinical trials using a digital platform.
Source: pharmaphorum.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 3Amylyx plummets as confirmatory trial of ALS drug fails - 2 month(s) ago
Amylyx crashes after it reports a confirmatory trial of its amyotrophic lateral sclerosis therapy Relyvrio missed all its objectives, putting its 2022 approval in jeopardy.
Source: pharmaphorum.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 0RYSE’s $50m digital health fund makes first investment - 2 month(s) ago
RYSE closes its first digital health fund, raising $50 million, and selects Spanish ADHD detection and treatment company Braingaze as the first investment.
Source: pharmaphorum.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 123andMe, Novartis team up to put Lp(a) on patients’ radar - 2 month(s) ago
Lipoprotein(a) is well established as a risk factor for cardiovascular disease, but patients rarely get tested for it. Now, an alliance between Novartis and genetic testing specialist 23andMe is trying to encourage greater awareness of Lp(a) and improve testing rates. The pilot programme will see a confidential test for Lp(a) offered to 23andMe customers. If they have high levels, they can then be connected to clinicians through 23andMe’s telehealth arm – Lemonaid – to get advice on the next steps. At
Source: pharmaphorum.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 10Bavarian Nordic gets swift EU review of chikungunya shot - 2 month(s) ago
Bavarian Nordic will get an accelerated review of its chikungunya vaccine CHIKV VLP at the EMA, as it tries to chase down a lead held by rival Valneva.
Source: pharmaphorum.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0FDA fast-tracks GSK’s chronic hep B therapy bepirovirsen - 3 month(s) ago
GSK’s antisense-based drug for chronic hepatitis B, bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval.
Source: pharmaphorum.comCategories: General Medicine News, Infectious DiseaseTweet
How do we unlock the potential of digital health? https://t.co/8fHp1tw7zS https://t.co/K0z2GyOo0Q